Comparative Efficacy of Liver Fibrosis & Steatosis Assessment With

Status Completed

Clinical Trial Summary

This study is aimed to compare the results and operating characteristics of liver stiffness measurement with the use of Fibroscan (EchoSens, France) and iLivTouch (Wuxi Hisky Medical Technologies Co., China) in patients with chronic liver diseases.

Clinical Trial Description

This is prospective comparative trial to assess diagnostic characteristics of non-invasive methods of liver fibrosis and steatosis assessment based on the measurement of liver stiffness. The null hypothesis is that novel device, iLivTouch FT100/FT200 and standard probe allows to obtain similar results of liver stiffness and controlled attenuation parameter compared to FibroScan 530 and probes M+ and XL+ in patients with chronic liver diseases. According to the study protocol, standard examination will be performed to eligible subjects on the same day with the use of both devices. At least 10 measurements will be performed with the use of each device to each subject after overnight fasting. The medians of liver stiffness and controlled attenuation parameter measurements, their interquartile range, success rate of measurements and related interpretations of the results (grades of liver fibrosis and steatosis) will be compared. To assess the variability of the results, demographic data (age, biological sex, ethnicity) will be collected; weight and height of the subjects will be measured on the day of examination. Medical history of the subjects will be examined to extract data, confirming the presence of chronic liver diseases and ensure eligibility. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05224037
Study type	Interventional
Source	Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Contact
Status	Completed
Phase	N/A
Start date	January 21, 2022
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06308757` - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis	N/A
Recruiting	`NCT06051669` - Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US
Completed	`NCT06244550` - Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors	N/A
Recruiting	`NCT06098417` - Biomarkers in the Diagnosis and Prognosis of NAFLD
Not yet recruiting	`NCT03623360` - Functional MRI to Determine Severity of Cirrhosis
Recruiting	`NCT01965418` - A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial	Phase 4
Not yet recruiting	`NCT01133184` - Improved Prevention of Perinatal Hepatitis B Transmission	Phase 4
Completed	`NCT00043303` - Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis	Phase 2
Completed	`NCT03872024` - Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients	N/A
Recruiting	`NCT05912179` - Prospective Single Centre Observational Study to Compare the Diagnostic Yield of Different Modalities of Liver Biopsy
Recruiting	`NCT04533828` - 68Ga-FAPI PET/CT in Liver Fibrosis Patients	Early Phase 1
Completed	`NCT04573543` - The Role of Immune Semaphorins in NAFLD
Recruiting	`NCT03277651` - Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension	N/A
Completed	`NCT01707472` - Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis	Phase 2
Not yet recruiting	`NCT05935488` - Early Liver Disease Breath Detection
Completed	`NCT01934777` - Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis	Phase 3
Completed	`NCT01988753` - Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
Completed	`NCT02060162` - Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Completed	`NCT01810458` - Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Completed	`NCT00049842` - Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)	Phase 3

Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch — OGIG-01-22-LF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms